Price cuts and generics among key topics in Japanese reform talks
This article was originally published in Scrip
Executive Summary
Japan's Central Social Insurance Medical Council (Chuikyo) has laid out a series of drug pricing topics for discussion, some of which may have the research-based industry feeling nervous.